In this insightful discussion, Dan Sfera and Darshan Kulkarni explore how clinical trial advertising is evolving in today’s highly regulated environment. They share perspectives on balancing outreach with compliance, highlight the critical role of patient advocacy in building trust, and discuss strategies to ensure ethical and effective communication with diverse patient populations. Together, they examine the future of clinical trials, where transparency, accessibility, and patient engagement play a central role.